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Abstract
Background: Despite being a preventable disease, cervical cancer claims the lives of almost half a
million women worldwide each year. India bears one-fifth of the global burden of the disease, with
approximately 130,000 new cases a year. In an effort to assess the need and potential for improving
the quality of cervical cancer prevention and treatment services in Uttar Pradesh, a strategic
assessment was conducted in three of the state's districts: Agra, Lucknow, and Saharanpur.
Methods: Using an adaptation of stage one of the World Health Organization's Strategic Approach
to Improving Reproductive Health Policies and Programmes, an assessment of the quality of cervical
cancer services was carried out by a multidisciplinary team of stakeholders. The assessment
included a review of the available literature, observations of services, collection of hospital statistics
and the conduct of qualitative research (in-depth interviews and focus group discussions) to assess
the perspectives of women, providers, policy makers and community members.
Results: There were gaps in provider knowledge and practices, potentially attributable to limited
provider training and professional development opportunities. In the absence of a state policy on
cervical cancer, screening of asymptomatic women was practically absent, except in the military
sector. Cytology-based cancer screening tests (i.e. pap smears) were often used to help diagnose
women with symptoms of reproductive tract infections but not routinely screen asymptomatic
women. Access to appropriate treatment of precancerous lesions was limited and often
inappropriately managed by hysterectomy in many urban centers. Cancer treatment facilities were
well equipped but mostly inaccessible for women in need. Finally, policy makers, community
members and clients were mostly unaware about cervical cancer and its preventable nature,
although with information, expressed a strong interest in having services available to women in
their communities.
Conclusion:  To address gaps in services and unmet needs, state policies and integrated
interventions have the potential to improve the quality of services for prevention of cervical cancer
in Uttar Pradesh.
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Background
Cancer of the cervix is preventable, yet approximately
493,100 new cases and more than 273,000 deaths occur
each year among women worldwide. [1] While evidence
of effective screening programs can be seen throughout
the developed world, the burden and impact of the dis-
ease remains high in developing countries, where 85% of
disease related deaths occur [1].
India, which accounts for one sixth of the world's popula-
tion, also bears one fifth of the world's burden of cervical
cancer [2]. There are approximately 130,000 new cases of
cervical cancer in India per year and the disease is reported
to be responsible for almost 20 percent of all female
deaths there [1]. India's cervical cancer age-standardized
incidence rate (30.7 per 100,000) and age-standardized
mortality rate (17.4 per 100,000) are the highest in South
Central Asia [1]. Data from Mumbai suggest that there
may have been a slight decline in cervical cancer incidence
in recent years. However, the absolute incidence is still
very high, especially in rural areas, and the number of
cases grows due to high population growth [2]. Simulta-
neously, there is also evidence that India is on the verge of
a large HIV epidemic [3]. The Indian National AIDS Con-
trol Organization estimates that the number of people liv-
ing with HIV is approximately 5.1 million (38% of whom
are women)[4] This suggests cause for concern given the
strong association between HIV and HPV infections and
evidence of more rapid progression of HPV infections to
cervical neoplasia in HIV infected women [5].
Global evidence demonstrates that the key to reducing
cervical cancer morbidity and mortality is early detection
coupled with timely treatment of cervical precancerous
lesions [6]. Cervical cytology often referred to as the Pap
smear is perhaps the most well known of available screen-
ing methods. However, newer screening techniques such
as visual inspection methods and HPV-DNA testing have
also demonstrated potential for early detection in many
settings. These technologies are currently being assessed
by the Alliance for Cervical Cancer Prevention (ACCP) for
their use in developing countries. As critical as detection
is, the need for women with positive results to receive ade-
quate and timely treatment for dysplasia, is paramount.
Even in low resource settings, treatment can be offered
using low morbidity outpatient procedures such as cryo-
therapy or Loop Electrosurgical Excision Procedure
(LEEP)[7].
With early detection and timely treatment in mind, the
World Health Organization recommends that resource
poor nations screen all women at least once in a lifetime
with priority given to women at the age of 35–40 when
likely-to-progress, high- grade but treatable dysplasia can
be found [8]. There is some debate about whether this age
limit is too high, [9] especially in countries with high HIV
incidence, although recent data from South Africa, includ-
ing 20,000 women showed the mean age of cancer to be
51.6 years [10]. In India in 2003, 46.6% of HIV cases in
women occurred in the 15–29 years age group [4]. As in
many developing countries and resource-limited settings,
India does not have a national vertical or integrated pro-
gram for screening asymptomatic women and treatment
of precancerous lesions. Some Indian states offer ad hoc
cervical cancer prevention and treatment services; how-
ever, the quality, including access to such services, varies
largely by region partly due to the absence of related pol-
icies and standards for providing those services.
Uttar Pradesh is India's most populous state. The General
Directorate of Family Welfare in the Uttar Pradesh under
the Ministry of Health and Family Welfare in collabora-
tion with EngenderHealth, a non-governmental reproduc-
tive health organization and member of the Alliance for
Cervical Cancer Prevention conducted a strategic assess-
ment on the quality of cervical cancer prevention and
treatment services in three of the state's districts: Agra,
Lucknow, and Saharanpur. This article summarizes the
process and findings of the assessment and presents strat-
egies and recommendations proposed by the stakehold-
ers.
Methods
The assessment was designed to evaluate the quality and
accessibility of cervical cancer prevention and treatment
services and was conducted from March to August 2004.
The assessment used an adaptation of the first stage of the
Strategic Approach to Improving Reproductive Health
Policies and Programmes [11], an approach first used to
assess the quality of cervical cancer services in Bolivia in
2002 [12]. Guiding this strategic assessment process were
these three strategic questions:
1. Is it necessary to introduce policies and interventions for
screening, diagnosis and treatment of precancerous cervical
lesions in Uttar Pradesh?
2. Is it necessary to improve the quality of information manage-
ment systems and cancer registries for the prevention, diagno-
sis, and treatment of cervical cancer in Uttar Pradesh?
3. Is it necessary to improve services for the treatment of cervical
cancer in Uttar Pradesh?
The available literature was reviewed and field data were
collected during three consecutive weeks by a 30-person
multi-disciplinary team of stakeholders. The team
included representatives from the Uttar Pradesh Directo-
rate General of Family Welfare, policy-makers, adminis-
trators, statisticians, social scientists, researchers,Reproductive Health 2005, 2:11 http://www.reproductive-health-journal.com/content/2/1/11
Page 3 of 8
(page number not for citation purposes)
gynecologists, pathologists, public health specialists, cyto-
technicians, NGO representatives and community advo-
cates. Data on services were drawn from observations of
94 sites visited, including public, military and private sec-
tors facilities (Table 1). In-depth interviews and focus
group discussions were conducted with individuals from
key respondent groups, including clients, community
members, providers, and policy makers (Table 2). A 10-
member Technical Advisory Group guided the technical
aspects of this assessment. Observations were conducted
at sites where cervical cancer services were offered or could
potentially be offered as part of reproductive health serv-
ices. Using a combination of purposive and snowball
sampling participants and health facilities were identified
across 18 communities, including urban, peri-urban, and
rural communities. Based on the analysis of data from the
three districts, responses to the strategic questions were
formulated and presented to a wider audience at a meet-
ing in Lucknow. Findings were framed according to their
relationship with recognized elements of quality of cervi-
cal cancer prevention and treatment programs and serv-
ices [13,14]; 1) availability, organization and capacity of
services; 2) access to services; 3) community knowledge;
4) knowledge and practices of health service providers; 5)
training and professional development of providers; 6)
quality improvement, including supervision and moni-
toring; and 7) information systems and cancer registries.
Results
No state-based epidemiological data or policy on cervical
cancer prevention exists in Uttar Pradesh. Population-
based incidence and mortality data from surveillance sites
outside of Uttar Pradesh suggest that cervical cancer is the
primary or secondary cause of female related cancer
deaths in several urban centers, and may even be higher in
rural districts [15].
The strategic assessment identified some isolated cervical
cancer prevention and treatment services; however, well-
coordinated prevention and stage-appropriate treatment
services, particularly in the public sector and outside large
urban centers, were lacking. The quality, cost and accessi-
bility of the services varied according to the providing sec-
tor (public, private or military) and facility.
Availability, organization, and capacity of services
Screening for cervical precancer and cancer
There was no routine screening offered to asymptomatic
women in health care facilities, with the exception of a
few private providers and military hospitals. Those pro-
viders reported routinely screening asymptomatic women
above 35 years in three years interval by using Pap smears.
In the public sector, Pap smears were mostly limited to the
tertiary care level on an outpatient basis, and usually only
offered to women with symptoms of reproductive tract
Table 2: Sampling by Respondent Category (N = 1197 
respondents)
REPRODUCTIVE HEALTH SERVICES CLIENTS
Female RH Clients (FGD and IDI) 176
Male RH Clients (FGD and IDI) 35
Women with Cervical Cancer (IDI) 9
COMMUNITY MEMBERS
Women (FGD) 319
Men (FGD) 58
Community leaders/Influentials (IDI and FGD) 74
POLICY INFLUENTIALS
Policymakers, health authorities, health program directors (IDI) 71
PROVIDERS (Interviews and Focus Group Discussions)
Obstetricians/Gynecologists (IDI) 45
Other Physicians, Female Medical Officers, Medical Students, 
Interns (IDI and FGD)
136
Radiotherapists, technicians (IDI) 10
Nurses, Nursing Students, Paramedical Staff (IDI and FGD) 129
Chemists, Registered Medical Practitioners, Traditional Healers 
(IDI and FGD)
48
Researchers, Statisticians, Demographers (IDI) 14
Cytopathologists and Laboratory Personnel (IDI) 73
IDI – In-depth interviews
FGD – Focus group discussions
Table 1: Number of Sites Visited in all 3 Districts by Sector.
Public Sector
• Specialized Cancer Centers 3
• Tertiary Hospitals 2
• Second Referral Sites (District Hospital) 7
• First Referral Sites (Community and primary health centers) 15
• Maternal and Child Health Units 3
• Laboratories 5
Private Sector
• Private Doctors, Clinics, Nursing Homes, Hospitals 21
• Private Laboratories 19
• Community, Faith-based, and Non-Governmental 
Organizations
10
• Other 6
Military Sector
Military Hospitals 3
TOTAL SITES 94Reproductive Health 2005, 2:11 http://www.reproductive-health-journal.com/content/2/1/11
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infections or advanced cervical cancer. In the public and
private sector, women usually first received a pelvic exam-
ination by their gynecologists and were then either
referred to the hospital's pathology department or to a pri-
vate pathology laboratory for their Pap smear.
Cytopathology services
Laboratories showed large variation in the procedures
used for sample collection, processing, reading and
reporting of Pap smears. Few of the laboratories visited
were accredited for cytopathology, as required by the
Indian Association of Cytopathology (IAC). Mostly pri-
vate laboratories were unfamiliar with the IACs norms for
cytopathology services. Most sites were processing a small
number of Pap smears but had the capacity to handle a
significantly larger load if provided with additional
resources, principally, trained staff and supplies.
Diagnosis and treatment of precancer
Equipment and services for diagnosis and treatment of
precancerous lesions, including colposcopes and cryo-
therapy were readily available in military sector facilities
and a few private facilities, yet rarely available or function-
ing at public tertiary sites. Some sites had cryotherapy
equipment but were only using it to treat 'cervical ero-
sion'; few staff at these sites knew that it could be used to
treat cervical precancer. Thus, in the public sector and in
many private facilities, invasive inpatient procedures such
as hysterectomy were the first line of treatment and man-
agement of women with precancer, even for mild dyspla-
sia.
Cervical cancer treatment, including palliative care
Most women with cervical cancer were diagnosed at later
stages of the disease. Uttar Pradesh has 11 well-equipped
cancer treatment facilities. Radical surgery for treatment of
early stages of cancer and radiotherapy for later stages,
were available for private and military sector patients, but
was usually financially and geographically inaccessible for
public sector patients in two of the three districts. Fre-
quently, women using public services had to travel to
other districts in Uttar Pradesh or to New Delhi to receive
cancer treatment. Palliative care, including opioid treat-
ment for pain relief, for terminally ill women was even
less accessible. Only one non-governmental organization
had recently started providing palliative care services in
one of the assessment districts.
Factors influencing access to services
In addition to the limited numbers of highly centralized
services (Table 3), there were several factors affecting
women's access to cervical cancer prevention and treat-
ment services. Where offered, the poor organization of
services in the public sector (often depending on a single
provider's presence), translated into women having to
make numerous visits and increasing therefore the likeli-
hood of loss to follow-up.
The costs of services varied considerably by site and sector
(Table 4), but even in the public sector, consultation fees
coupled with the often high indirect costs of having to
seek services (e.g. transportation, lost wages, long waits)
were reported to negatively influence access. As one client
interviewed said, "the hospital is very far from my home. So it
takes a very long time and costs about Rs. 80 in transportation."
For many, this equivalent of two days wages was often too
costly.
Equally important, negative perceptions of the commu-
nity and clients about the quality of public sector services
were also reported to discourage clients from attending,
especially in the absence of symptoms. On client asked "if
Table 3: Availability of Cervical Cancer Services in the Public Sector in Uttar Pradesh
Health Care Level Description Services Available
First Referral Sites Rural community health centers, Primary 
health centers, and rural sub-centers
Only referrals of women with reproductive tract 
infections symptoms to district hospitals for Pap 
smears.
Second Referral Sites Urban district hospitals A few Pap smears performed on symptomatic 
women, treatment of precancer (cryotherapy* 
available but hysterectomy was most often used). In 
many secondary referral sites, women just referred 
to tertiary facilities.
Tertiary Hospitals Urban Medical Colleges and Universities Pap-tests, colposcopy, Treatment of precancer 
(cryotherapy* available but hysterectomy was most 
commonly performed), cancer treatments (radical 
surgery, radiotherapy or chemotherapy).
Specialized Oncology Treatment 
Centers (Under National Cancer Control 
Program)
11 in Uttar Pradesh state, with one in 
Lucknow; none in Agra or Saharanpur
A range of cancer treatment services, including 
surgery, radiotherapy, chemotherapy.
*Cryotherapy equipment and supplies were available in some sites; however, they were mostly used for treating "cervical erosion" but not for the treatment of 
precancerous lesions.Reproductive Health 2005, 2:11 http://www.reproductive-health-journal.com/content/2/1/11
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I do not have any pain or any other symptoms, why should I go
for examination?" These factors were often compounded
by the socio-cultural notions challenging women's com-
fort with having a pelvic examination, especially by a male
provider.
Issues of confidentiality and privacy were not just barriers
to women getting screening but were a reality for women
diagnosed with cervical cancer. As one woman undergo-
ing radiotherapy said, "The hardest part of this is that I have
lost my dignity. What was once private, I now have to discuss
with the doctor in front of my son." Male relatives were often
reported to play a key role as facilitators or gatekeepers to
women's access to services. Finally, given the limited
financial means of many community members, the value
of women's health and prevention of illness were often
reported as secondary to competing financial and social
responsibilities. As one provider explained, "for many of
the patients, meeting daily needs is more crucial; preventive
care and detecting cervical cancer is not the priority."
Community knowledge about cervical cancer
Information, Education and Communication (IEC) cam-
paigns on breast, prostate and oral cancers had raised
awareness in communities about the causes and preven-
tion of these diseases. This was not the case for cervical
cancer for which virtually no IEC materials or efforts pro-
moted its preventable nature in the vast majority of com-
munities and facilities visited. Where available,
counseling in tertiary facilities for women was often inad-
equate or incomplete. Most community members
reported familiarity with other forms of cancer, but rarely
knew of cervical cancer. Only very few community mem-
bers and clients who knew someone who had been diag-
nosed with cervical cancer reported some familiarity with
the disease, but also did not know that it was preventable.
Women's knowledge and perceptions
Few community members or asymptomatic women had
ever been screened for cervical cancer. Those who ever had
a Pap smear or were interviewed when they presented for
screening also did not know that the test could help in
preventing cervical cancer. Similarly, women interviewed
who were undergoing treatment for early and late stage
cervical cancer were often unaware of their exact diagnosis
or if aware, did not know the cause of the disease for
which they were being treated.
"I only know cancer by name. It is a disease which cannot be
treated. So a person dies. My grandmother had some genital
cancer about 5–6 years back. She was treated, but ultimately
she died. For many, including this female community
member, cervical cancer was commonly equated with
death. "I am ashamed of this disease in this old age," said one
woman interviewed who was undergoing radiotherapy
for cervical cancer. Since many believed that cervical can-
cer was caused by poor hygiene, high parity, promiscuity,
fibroids, and/or use of contraceptive pills or IUCD, many
reported fearing that a cervical cancer diagnosis would
bring a woman shame, blame and even abandonment by
her husband and family. Given such stigma, most women
with cervical cancer had not been told about the nature of
their disease, mostly at the request of family members.
Some women believed that cervical cancer is caused by
pelvic examination; this belief was based on the percep-
tion that it could activate or exacerbate dormant cancer
cells.
Men's knowledge
The perceptions of men from the community and male
clients were similar to those of women. Like women, male
respondents interviewed also had large knowledge gaps
and misconceptions about the cause of cervical cancer.
Some men reported discomfort discussing matters of
reproductive health or sexuality with women; yet, after
having learned the potential benefits of screening, most
were willing to encourage their wives and female relatives
to be screened. Most male clients at the military hospitals
were aware that women above the age of 35 years should
have regular examinations and undergo tests, but they
were not sure about why the tests were being performed
and did not know that cervical cancer is preventable.
Awareness among community leaders
Likewise, community leaders, while generally unaware of
the cause and magnitude of cervical cancer, were particu-
Table 4: Average Cost in Rupees ($1 = 45 Rupees) by Sector of Various Cervical Cancer Prevention and Treatment Services
Type of Service Public Private (For-profit and NGOs) Military
Consultation 1 1–300 Free or minimal charge
Pap Collection and Cytology 0–13 36–300 Free or minimal charge
Colposcopy 50 500 Free or minimal charge
Cryotherapy/LEEP 50 500 Free or minimal charge
Cervical Biopsy 50 150–250 Free or minimal charge
Hysterectomy 400 10,000–25,000 Free or minimal charge
Radiotherapy 900–5000 7,200–20,000 Free or minimal charge
Radical Surgery 400 25,000–40,000 Free or minimal chargeReproductive Health 2005, 2:11 http://www.reproductive-health-journal.com/content/2/1/11
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larly interested in learning how they could facilitate pre-
vention and awareness, particularly IEC and screening
campaigns. Many stressed the importance of access to
these services, particularly at the primary health care level.
One community leader said, "I will make cancer cervix on
the priority list. I will be the part of the team to make the com-
munity aware about the disease. I will involve ANMs (mid-
wives) to visit house to house so that they can talk to women one
on one basis. But the program should come to our community."
Providers' knowledge and practices
Many providers knew about the link between cervical can-
cer and Human Papilloma Virus (HPV), yet gaps in under-
standing the natural history of cervical cancer, its
preventable nature, treatment of precancerous lesions,
and knowledge of stage-appropriate clinical management
of cancer were present. Knowledge about cervical cancer
was generally better at higher-level facilities and in the pri-
vate and military sectors. Generally, more physicians were
aware about cervical cancer issues than mid-level and par-
amedical staff. It was not uncommon that doctors were
unaware of the long period during which precancerous
lesions could be detected and treated; which may explain
why few doctors were performing routine screening of
asymptomatic women or targeting younger women. Mili-
tary sector providers were generally more knowledgeable
about the importance of age-targeted interval screening
and population coverage strategies to reduce cervical can-
cer morbidity and mortality.
While familiar with Pap smears, few providers had knowl-
edge of alternative screening approaches, such as HPV-
testing and visual inspection methods (e.g. visual inspec-
tion with acetic acid (VIA) or visual inspection with
Lugol's iodine (VILI)). Most gynecologists in public and
private facilities felt competent in taking cervical samples
for Pap smears but said that they generally referred clients
to pathology labs for the pathologists, residents or female
technicians to take the cervical sample. Some reported
doing so for their own convenience while others believed
that laboratory personnel were better suited to take
smears. Observations and provider interviews suggested
that at least some of the cervical samples collected were of
poor quality due to noted gaps in provider practices, such
as using cotton swabs to collect samples or improperly
collecting the cervical smear.
"I treat dysplasia I and II with an antibiotic and antioxidant
course for three months then repeat the Pap smear. If it
progresses or remains the same, I advise hysterectomy."
Similar to this public sector provider, most doctors did
not differentiate between an indication for treating pre-
cancerous lesions and cancer, usually performing a hyster-
ectomy to manage most forms of dysplasia. Mid-level and
nursing staff rarely knew the difference between cervical
precancer and cancer or about stage-appropriate treat-
ments. Additionally, few public sector providers had been
trained or had access to colposcopes for cervical cancer
diagnosis. Access to and knowledge of the value of simple
and effective precancer treatments such as cryotherapy
and LEEP were also limited among providers in the public
sector, but considerably better among private and military
sector providers and public sector oncologists and radio-
therapists. Knowledge about palliative care, including
pain relief, as a way of providing clinical and psychosocial
support for terminally ill patients, was generally poor
among most providers.
Training and professional development of health care 
providers
Discussion with providers and those responsible for train-
ing medical and nursing students revealed that there was
limited access to relevant pre-service training programs
and few professional development opportunities. Few
medical teaching institutions were routinely training
gynecology residents to perform Pap smears, colposcopy
or cryotherapy. Those responsible for offering cancer
treatment generally had formal postgraduate training in
radiotherapy. Pathologists generally reported having
received postgraduate training in reading cervical smears
but had learned to take Pap smears on-the-job. Cervical
cancer issues were not included in the theoretical or prac-
tical training of nurses. Staff at almost all laboratories
reported a shortage of formally trained cytotechnicians.
Most laboratories were instead relying on in-house
trained technicians.
There were few opportunities for continuing professional
development in reproductive female oncology. The Feder-
ation of Obstetric and Gynecological Society of India had
recently published a review of screening methods and
approaches, but few gynecologists were even aware of this
resource. Similarly, national organizations such as the
Indian Medical Association and the Indian Association of
Cytopathology were rarely mentioned as sources of infor-
mation on cervical cancer issues.
Quality improvement and quality assurance
Functioning quality improvement systems, which include
effective supervision and monitoring, are key aspects of
any health program. Internal and external laboratory
quality assurance systems were not available in most lab-
oratories. Most ad-hoc cervical cancer services were not
based on any official policy and were generally integrated
into the services provided by several departments (gyne-
cology, pathology, and oncology) without clear guidance
and indicators of what constituted quality and how it
should be monitored. Although some facilities initially
reported that they had internal quality assessment sys-Reproductive Health 2005, 2:11 http://www.reproductive-health-journal.com/content/2/1/11
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tems, there was little evidence of these in most sites vis-
ited.
Information systems and cancer registries
Firstly, cancer registries contain data that can be used to
track and follow-up patients. Secondly, they can quantify
the magnitude of morbidity and mortality associated with
the disease. In Uttar Pradesh, neither information systems
nor cancer registries existed. Even facility-based data, col-
lected routinely by districts on infectious and communi-
cable diseases did not include any indicators or data on
cervical cancer.
A few private and military sites were found to be using
high tech computerized systems to capture client data for
tracking and billing, but more commonly non-standard-
ized manual registries were used by the sites. Referrals and
follow-up were generally presumed to be the patient's
responsibility, and few sites tracked those with positive
Pap smear results. At some sites as many as 80% of
women were said to have failed to return for their results.
Follow-up was rarely conducted to track clients with cervi-
cal precancer or cancer.
Discussion
These findings reveal a large need for the expansion of cer-
vical cancer prevention and treatment services in the pub-
lic and private sectors. To develop cost-effective strategies
for improving quality and increasing access, responses to
the three strategic questions were considered by the stake-
holders:
Is it necessary to introduce policy and interventions for 
screening, diagnosis, and treatment of precancerous 
cervical lesions?
While there were some services providing screening and
treatment of cervical precancerous lesions, staff was often
managing services with little guidance. National guide-
lines on cervical cancer prevention and management
should be provided. Policies should be considered in the
light of multiple competing health priorities in Uttar
Pradesh and should build on existing resources and serv-
ices, provider and system capacities, and community per-
ceptions. State-level policy should include an emphasis
on pre-service medical education. Professional institu-
tions may be the key to reach existing and future genera-
tions of providers with the knowledge and skills needed to
deliver effective services. This assessment confirmed find-
ings from studies in similar settings that many providers
were unaware of the natural history of HPV infection and
the appropriate timing and frequency of screening inter-
ventions. Orientation of international guidelines on tar-
get age groups, screening frequency and the need for
increased coverage is urgently needed.
To address the lack of awareness and knowledge among
providers, clients and the community at large, IEC materi-
als about cervical cancer and its prevention should be
developed and disseminated along with information for
women over 35 years old on where and how to get
screened. Simultaneously, interventions are needed to
meet the demand by maximizing the capacity of existing
technologies and resources with linkages to the primary
community level. In particular, program planners should
look at the possibility of providing counseling and screen-
ing for cervical cancer in the voluntary counseling and
testing centers for HIV (VCT), of which there are currently
70 in Uttar Pradesh [4].
Is it necessary to improve the current information system 
and cancer registry for the prevention, diagnosis and 
treatment of cervical cancer?
Since screening without the possibility for treatment
would be pointless, functional mechanisms for tracking
women for follow-up care need to be introduced. As sug-
gested by community leaders, NGOs and community
groups should be engaged to play a key role in these
aspects, provided attention is paid to confidentiality and
clients' rights. Opportunities for collecting population-
based data on coverage, morbidity and mortality should
also be considered as interventions to be integrated into
reproductive health services. The potential of linking with
state-based and national information systems to collect
these data should also be explored.
Is it necessary to improve the existing services for the 
treatment and management of cervical cancer?
Given that there are 11 well-equipped cancer treatment
centers in Uttar Pradesh, stronger linkages and referral sys-
tems to these facilities are needed, particularly for women
in districts with limited services. The costs of transport and
lodging for women and their families could potentially be
offset by community and NGO supported mechanisms.
Within these facilities and at the community level,
emphasis should also be given to palliative care for termi-
nally ill women.
Conclusion
As prophylactic and therapeutic HPV vaccines are still
under development, and evidence that other primary pre-
vention measures are not useful [16], secondary preven-
tion, in the form of screening and treatment of
precancerous lesions continues to be the most effective
way to reduce the incidence of cervical cancer at the
present time. Findings of the strategic assessment reveal
the need for policies and interventions to expand
women's access to cervical screening and treatment facili-
ties. In his regard, India is not different from other low
resource settings, where programs are lacking or failing
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poor quality services, outdated knowledge and unin-
formed consumers. As in other settings, political will and
resources, need to be made available. Even without large
resources, it is possible to develop programs by assessing
needs, re-assigning existing resources more wisely and cre-
ating synergies between different stakeholders. For exam-
ple, it is useful to focus limited staff and laboratory
resources on screening women in key age groups, rather
than on very young women. It might also be useful to cre-
ate new linkages with services that focus on older women,
for example, hypertensive clinics, or those who manage
clients at high risk of contracting HIV.
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